Medicare Enrolled

Dr. Deepti Kallam, MD

Medical Oncology · Dallas, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3107 W CAMP WISDOM RD STE 110, Dallas, TX 75237
2147652222
In practice since 2013 (12 years)
NPI: 1609209949 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kallam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kallam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kallam

Dr. Deepti Kallam is a medical oncology specialist in Dallas, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Kallam performed 178 Medicare services across 134 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kallam received a total of $3,484 from 44 pharmaceutical and/or device companies across 133 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kallam is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ 178 Medicare services $3,484 industry payments

Medicare Practice Summary

Medicare Utilization ↗
178
Medicare services
Bottom 15% in TX for medical oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
134
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~15 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 85 $71 $145
Office visit, established patient (20-29 min) 52 $50 $98
New patient office visit, complex (60-74 min) 24 $136 $269
New patient office visit (45-59 min) 17 $102 $205
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,484
Total received (2018-2024)
Avg $498/year across 7 years
Bottom 48% in TX for medical oncology
44
Companies
133
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,079 (59.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$824 (23.6%)
Other
Charitable contributions, space rental, and other categories
$581 (16.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$132
2023
$726
2022
$1,093
2021
$847
2020
$261
2019
$84
2018
$340

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$435
Novartis Pharmaceuticals Corporation
$361
Janssen Biotech, Inc.
$334
NOVARTIS PHARMACEUTICALS CORPORATION
$309
Amgen Inc.
$221
Kite Pharma, Inc.
$219
Merck Sharp & Dohme Corporation
$160
PFIZER INC.
$156
ABBVIE INC.
$132
Regeneron Healthcare Solutions, Inc.
$114
Rigel Pharmaceuticals, Inc.
$96
E.R. Squibb & Sons, L.L.C.
$85
AstraZeneca Pharmaceuticals LP
$74
Lilly USA, LLC
$69
Takeda Pharmaceuticals U.S.A., Inc.
$50
Myovant Sciences Inc.
$49
Coherus Biosciences Inc.
$49
Incyte Corporation
$47
Pharmacyclics LLC, An AbbVie Company
$45
PUMA BIOTECHNOLOGY, INC.
$44
ARRAY BIOPHARMA INC
$37
Verastem, Inc.
$24
GE HealthCare
$24
Sobi, Inc
$24
Genmab U.S., Inc.
$21
Merck Sharp & Dohme LLC
$20
EISAI INC.
$19
Ipsen Biopharmaceuticals, Inc
$19
GENZYME CORPORATION
$18
EMD Serono, Inc.
$17
ADC Therapeutics America, Inc.
$17
MorphoSys, US Inc.
$17
TAIHO ONCOLOGY, INC.
$16
Alexion Pharmaceuticals, Inc.
$16
Dova Pharmaceuticals
$16
Eisai Inc.
$16
Lexicon Pharmaceuticals, Inc.
$16
Foundation Medicine, Inc.
$15
Sumitomo Pharma America, Inc.
$15
Myriad Genetic Laboratories, Inc.
$15
Seagen Inc.
$15
Bayer HealthCare Pharmaceuticals Inc.
$14
Celgene Corporation
$14
G1 Therapeutics, Inc.
$11
Top 3 companies account for 32.4% of total payments
Associated products mentioned in payments ›
BRAFTOVI · COSELA · Copiktra · DARZALEX · DOPTELET · Doptelet · EPKINLY · ERLEADA · FOUNDATIONONE LIQUID CDX · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · INREBIC · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nplate · OPDIVO · ORGOVYX · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · Padcev · SARCLISA · SOMATULINE DEPOT · Stivarga · TAGRISSO · TIVDAK · TUKYSA · Tavalisse · ULTOMIRIS · Udenyca · XALKORI · XGEVA · XTANDI · Xermelo · Xtandi · Yescarta · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,957 per 100 Medicare services performed
Looking for a medical oncology specialist in Dallas?
Compare medical oncologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
81
Per 100K population
3.1
County median income
$74,149
Nearest hospital
METHODIST CHARLTON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kallam is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kallam experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kallam performed 85 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kallam receive payments from pharmaceutical companies?
Yes. Dr. Kallam received a total of $3,484 from 44 companies across 133 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kallam's costs compare to other medical oncologists in Dallas?
Dr. Kallam's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kallam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →